home / stock / phrm:cc / phrm:cc news

PHRM:CC News and Press, Pharmather Holdings Ltd. From 10/23/25

Stock Information
Company Name: Pharmather Holdings Ltd.
Stock Symbol: PHRM:CC
Market: CNQC
Website: pharmather.com
Menu
PHRM:CC PHRM:CC Quote PHRM:CC Short PHRM:CC News PHRM:CC Articles PHRM:CC Message Board
Get PHRM:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
PHRM:CC - Canadian Companies Moving the Markets, Evening edition
Thu, Oct 23, 2025 as of 4:00 pm ET

A look at the top 10 most actives in Canada Cenovus Energy Inc. (CVE) rose 3.1% to $24.18 on volume of 31,946,759 shares Whitecap Resources Inc. (WCP) rose 2.7% to $10.5 on volume of 23,349,301 shares Bitfarms Ltd. (BITF) rose 8.7% to $5.87 on volume of 17,865,354 shares Canadian Natural ...
PHRM:CC - PharmaTher Applauds FDA's Commissioner's National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale

Toronto, Ontario--(Newsfile Corp. - October 17, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty life sciences company focused on unlocking the pharmaceutical potential of ketamine, today applauds the U.S. Food and Drug Administration's ("FD...

PHRM:CC - PharmaTher Advances Phase 3 FDA Package for Ketamine in LID-Parkinson's Disease

Company preparing FDA meeting package to align on a single, well-controlled Phase 3 study under 505(b)(2); Pharma partner discussions ongoing Toronto, Ontario--(Newsfile Corp. - October 16, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a s...

PHRM:CC - PharmaTher Announces KetAImine(TM) - AI Discovery Platform to Expand the Ketamine Portfolio, Enable Earlier Partnering, and Fast-Track 505(b)(2) NDA Filings

Expanding ketamine indications, fortifying IP, enabling earlier partnerships, and accelerating FDA pathways - underpinned by PharmaTher's Digital Health AI division, leveraging the Company's FDA-approved ketamine ANDA CMC and KetaVault(TM) data advantage. Toronto, Ontario--(Newsfile Corp. - Octo...
PHRM:CC - CSE Bulletin: MOC Eligibility Update

Toronto, Ontario--(Newsfile Corp. - October 9, 2025) - The following CSE-Listed symbol will become MOC Eligible as detailed below.   The full list of MOC-Eligible symbols is available at https://thecse.com/trading/trading-resources/#market-on-close . For further information, ple...

PHRM:CC - PharmaTher Provides Update on Ketamine Program for LID-Parkinson's Disease

Phase 3 program targeting a potential US$2.2B U.S. market opportunity 505(b)(2) regulatory path leveraging prior human data to reduce risk, cost, and time FDA-reviewed CMC package validated through prior ANDA approval Patent coverage to 2036 for ketamine in Parkinson's and related motor ...

PHRM:CC - PharmaTher Provides Corporate Update on Ketamine Development and Commercial Strategy

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to provide a corporate update following its recently announc...
PHRM:CC - Canadian Companies Moving the Markets, Evening edition
Wed, Oct 01, 2025 as of 4:00 pm ET

A look at the top 10 most actives in Canada Guanajuato Silver Company Ltd. (GSVR) fell 13.9% to $0.465 on volume of 51,942,548 shares Prospector Metals Corp. (PPP) rose 283.6% to $1.17 on volume of 26,205,206 shares Bitfarms Ltd. (BITF) fell 0.5% to $3.91 on volume of 17,831,666 shares B2...

PHRM:CC - PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate over US$25 Million in Milestone and Profit-Sharing Payments

Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the "Company" or "PharmaTher"), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that it has entered into a definitiv...

PHRM:CC - PharmaTher Announces Sale of Ketamine ANDA with Potential to Generate Over US$25 Million in Milestone and Profit-Sharing Payments

TORONTO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, is pleased to announce that it has entered into a definitive Asset Purc...
Previous 10 Next 10